Display options
Cite
Prokofjeva MM, Kochetkov SN, Prassolov VS. Therapy of HIV Infection: Current Approaches and Prospects. Acta Naturae. 2016;8(4):23-32
Prokofjeva, M. M., Kochetkov, S. N., & Prassolov, V. S. (2016). Therapy of HIV Infection: Current Approaches and Prospects. Acta naturae, 8(4), 23-32.
Prokofjeva, M M, et al. "Therapy of HIV Infection: Current Approaches and Prospects." Acta naturae vol. 8,4 (2016): 23-32.
Prokofjeva MM, Kochetkov SN, Prassolov VS. Therapy of HIV Infection: Current Approaches and Prospects. Acta Naturae. 2016 Oct-Dec;8(4):23-32. PMID: 28050264; PMCID: PMC5199204.
Copy Download .nbib Format: NLM
Share it on

Acta Naturae. 2016 Oct-Dec;8(4):23-32.

Therapy of HIV Infection: Current Approaches and Prospects.

Acta naturae

M M Prokofjeva, S N Kochetkov, V S Prassolov

Affiliations

  1. Engelhardt Institute of Molecular Biology, Vavilova Str., 32, Moscow, 119991, Russia.

PMID: 28050264 PMCID: PMC5199204

Abstract

The human immunodeficiency virus type 1 (HIV-1) is the causative agent of one of the most dangerous human diseases - the acquired immune deficiency syndrome (AIDS). Over the past 30 years since the discovery of HIV-1, a number of antiviral drugs have been developed to suppress various stages of the HIV-1 life cycle. This approach has enables the suppression of virus replication in the body, which significantly prolongs the life of HIV patients. The main downside of the method is the development of viral resistance to many anti-HIV drugs, which requires the creation of new drugs effective against drug-resistant viral forms. Currently, several fundamentally new approaches to HIV-1 treatment are under development, including the use of neutralizing antibodies, genome editing, and blocking an integrated latent provirus. This review describes a traditional approach involving HIV-1 inhibitors as well as the prospects of other treatment options.

Keywords: HIV-1; antiviral therapy; genome editing; viral life cycle inhibitors

References

  1. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7 - PubMed
  2. J Biol Chem. 2001 May 25;276(21):18102-7 - PubMed
  3. J Med Chem. 2005 Mar 24;48(6):1901-9 - PubMed
  4. Biochemistry. 1995 Apr 4;34(13):4346-53 - PubMed
  5. Nat Med. 2003 Jun;9(6):727-8 - PubMed
  6. J Med Chem. 2004 Oct 21;47(22):5567-78 - PubMed
  7. N Engl J Med. 2014 Mar 6;370(10):901-10 - PubMed
  8. Lancet HIV. 2014 Oct;1(1):e13-21 - PubMed
  9. Science. 1988 Nov 25;242(4882):1171-3 - PubMed
  10. Nat Biotechnol. 2013 Mar;31(3):230-2 - PubMed
  11. Science. 1990 Apr 20;248(4953):358-61 - PubMed
  12. Antimicrob Agents Chemother. 1992 Dec;36(12):2686-92 - PubMed
  13. Antiviral Res. 2010 Jan;85(1):59-74 - PubMed
  14. Curr Opin Struct Biol. 2008 Apr;18(2):203-17 - PubMed
  15. PLoS Pathog. 2015 Sep 17;11(9):e1005142 - PubMed
  16. Nature. 2015 Jun 25;522(7557):487-91 - PubMed
  17. Immunol Rev. 2013 Jul;254(1):355-71 - PubMed
  18. Nature. 2012 Jul 25;487(7408):482-5 - PubMed
  19. Nat Med. 1997 Aug;3(8):922-4 - PubMed
  20. Curr Med Chem. 2006;13(11):1305-15 - PubMed
  21. Mar Drugs. 2013 Aug 19;11(8):3000-14 - PubMed
  22. Int J Biochem Cell Biol. 2004 Sep;36(9):1687-705 - PubMed
  23. Chem Biodivers. 2004 Jan;1(1):44-64 - PubMed
  24. Antimicrob Agents Chemother. 1992 Nov;36(11):2423-31 - PubMed
  25. Curr Drug Metab. 2004 Aug;5(4):305-16 - PubMed
  26. N Engl J Med. 2009 Feb 12;360(7):692-8 - PubMed
  27. N Engl J Med. 2008 Jul 24;359(4):339-54 - PubMed
  28. J Am Chem Soc. 2005 Dec 14;127(49):17253-60 - PubMed
  29. AIDS Res Hum Retroviruses. 1992 Feb;8(2):145-52 - PubMed
  30. Biochemistry. 1993 Jul 6;32(26):6548-54 - PubMed
  31. Antimicrob Agents Chemother. 1988 Nov;32(11):1742-5 - PubMed
  32. N Engl J Med. 2008 Jul 24;359(4):355-65 - PubMed
  33. Antimicrob Agents Chemother. 2003 Mar;47(3):889-96 - PubMed
  34. J Biol Chem. 2006 Sep 22;281(38):27744-52 - PubMed
  35. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3862-6 - PubMed
  36. AIDS Res Hum Retroviruses. 1993 Nov;9(11):1051-3 - PubMed
  37. Science. 1995 Jan 27;267(5197):483-9 - PubMed
  38. Antiviral Res. 2010 Jan;85(1):39-58 - PubMed
  39. Antimicrob Agents Chemother. 2002 Jul;46(7):2179-84 - PubMed
  40. Antiviral Res. 2010 Jan;85(1):75-90 - PubMed
  41. Nat Rev Drug Discov. 2004 Mar;3(3):215-25 - PubMed
  42. Sci Rep. 2013;3:2510 - PubMed
  43. J Med Chem. 2000 Oct 5;43(20):3799-802 - PubMed
  44. Science. 1989 Mar 31;243(4899):1731-4 - PubMed
  45. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):483-93 - PubMed
  46. Lancet. 2007 Jul 7;370(9581):39-48 - PubMed
  47. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1451-5 - PubMed
  48. Antiviral Res. 2006 Sep;71(2-3):77-89 - PubMed
  49. Antimicrob Agents Chemother. 1992 Nov;36(11):2432-8 - PubMed
  50. J Virol. 1996 Nov;70(11):8010-8 - PubMed
  51. J Biol Chem. 1998 May 8;273(19):11491-7 - PubMed
  52. N Engl J Med. 2004 Mar 4;350(10):1023-35 - PubMed
  53. Nat Struct Biol. 1997 Aug;4(8):601-4 - PubMed
  54. Antimicrob Agents Chemother. 1986 Dec;30(6):933-7 - PubMed
  55. Br Med Bull. 2001;58:43-59 - PubMed
  56. AIDS. 2002 Oct 18;16(15):2035-41 - PubMed
  57. J Infect Dis. 1998 Oct;178(4):1163-6 - PubMed
  58. Biochem Biophys Res Commun. 2007 Jan 12;352(2):341-50 - PubMed
  59. Rev Med Virol. 2009 Sep;19(5):287-99 - PubMed
  60. Science. 2000 Jan 28;287(5453):646-50 - PubMed
  61. J Exp Med. 2014 Sep 22;211(10):2061-74 - PubMed
  62. Structure. 2000 Oct 15;8(10):1089-94 - PubMed
  63. Immunity. 2012 Mar 23;36(3):491-501 - PubMed
  64. Lancet. 2007 Apr 14;369(9569):1261-9 - PubMed
  65. J Biol Chem. 1997 Dec 5;272(49):30603-6 - PubMed
  66. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8046-9 - PubMed
  67. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8495-9 - PubMed
  68. Lancet. 2007 Jul 7;370(9581):29-38 - PubMed
  69. Science. 2004 Jul 9;305(5681):205-8 - PubMed
  70. PLoS One. 2014 Dec 26;9(12):e115987 - PubMed

Publication Types